Evidence-levels in pathology for informing the WHO classification of tumours

Affiliations

¹ WHO Classification of Tumours Programme, International Agency for Research on Cancer, World Health Organisation, Lyon, France.
² Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
³ Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
⁴ School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
⁵ Division of Pathology, Singapore General Hospital, Singapore.

Editorial

Blanca Iciar Indave et al. Histopathology. 2022 Oct.

. 2022 Oct;81(4):420-425.

doi: 10.1111/his.14648.

¹ WHO Classification of Tumours Programme, International Agency for Research on Cancer, World Health Organisation, Lyon, France.
² Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
³ Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
⁴ School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
⁵ Division of Pathology, Singapore General Hospital, Singapore.

No abstract available

Keywords: WHO Classification of tumours; evidence levels; evidence-based pathology.

References

1. Uttley L, Indave BI, Hyde C, White V, Lokuhetty D, Cree I. Invited commentary - WHO classification of tumours: how should tumors be classified? Expert consensus, systematic reviews or both? Int. J. Cancer 2020; 146; 3516-3321.
1. Masic I, Miokovic M, Muhamedagic B. Evidence based medicine - new approaches and challenges. Acta Inform. Med. 2008; 16; 219-225.
1. Higgins JPGS. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration and John Wiley & Sons Ltd: West Sussex, UK, 2008.
1. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009; 339; b2700.
1. Page MJ, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372; n71.